Media Summary: Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses different Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... Jill Corre, PharmD, PhD, of L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, ...
Methods Used To Assess Mrd - Detailed Analysis & Overview
Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses different Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... Jill Corre, PharmD, PhD, of L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, ... Elena Zamagni, MD, PhD from the University of Bologna, Bologna, Italy discusses the Graham Jackson, MBBS, FRCP, FRCPath, MD, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK, discusses the ... Mattia D'Agostino, MD, University of Turin, Turin, Italy, gives guidance on
Overview of the science behind Molecular Residual Disease ( Elena Zamagni, MD, PhD, of the University of Bologna, Bologna, Italy, discusses the importance of combining In this video, Mark Roschewski, MD, National Cancer Institute, Bethesda, MD, shares his insights into the In this video, after explaining what MRD is, Hammond talks about the different Watch this Quick Guide on Measurable Residual Disease ( Dr. Ola Landgren of The Sylvester Comprehensive Cancer Center at the University of Miami Health System is a pioneer in
Experts expand on the practical and clinical Carlos Fernandez de Larrea, MD, PhD from the Hospital Clínic de Barcelona, Barcelona, Spain discusses which Jacqueline Cloos, PhD, Amsterdam UMC, Amsterdam, The Netherlands, shares some insights into the importance of considering ... Costa Bachas, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, comments on the retrospective validation of ...
